BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38643489)

  • 1. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.
    Xiao CK; Ren Y; Chen Q; Yang Y; Tang L; Xu L; Ren Z
    Epigenetics; 2024 Dec; 19(1):2343593. PubMed ID: 38643489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
    Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
    Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
    Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
    Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
    Wang B; Zhou M; Gan XL; Ren YX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
    Int J Clin Oncol; 2023 Sep; 28(9):1147-1157. PubMed ID: 37428307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
    Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
    Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of H3K9me3 with breast cancer prognosis by estrogen receptor status.
    Zhou M; Yan JQ; Chen QX; Yang YZ; Li YL; Ren YX; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
    Clin Epigenetics; 2022 Oct; 14(1):135. PubMed ID: 36303253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.
    Elsheikh SE; Green AR; Rakha EA; Powe DG; Ahmed RA; Collins HM; Soria D; Garibaldi JM; Paish CE; Ammar AA; Grainge MJ; Ball GR; Abdelghany MK; Martinez-Pomares L; Heery DM; Ellis IO
    Cancer Res; 2009 May; 69(9):3802-9. PubMed ID: 19366799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival is associated with repressive histone trimethylation markers in both HR-positive HER2-negative and triple-negative breast cancer patients.
    Wang B; Zhou M; Shi YY; Chen XL; Ren YX; Yang YZ; Tang LY; Ren ZF
    Virchows Arch; 2023 Jun; 482(6):1047-1056. PubMed ID: 37059917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
    Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
    Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.
    Healey MA; Hu R; Beck AH; Collins LC; Schnitt SJ; Tamimi RM; Hazra A
    Breast Cancer Res Treat; 2014 Oct; 147(3):639-51. PubMed ID: 25224916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of histone marks H3K9me3 and H4K20me3 in cancer.
    Leszinski G; Gezer U; Siegele B; Stoetzer O; Holdenrieder S
    Anticancer Res; 2012 May; 32(5):2199-205. PubMed ID: 22593510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer.
    Benard A; Goossens-Beumer IJ; van Hoesel AQ; de Graaf W; Horati H; Putter H; Zeestraten EC; van de Velde CJ; Kuppen PJ
    BMC Cancer; 2014 Jul; 14():531. PubMed ID: 25047223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Dynamic Profiling of Histone Methylation during Nuclear Transfer-Mediated Porcine Somatic Cell Reprogramming.
    Cao Z; Li Y; Chen Z; Wang H; Zhang M; Zhou N; Wu R; Ling Y; Fang F; Li N; Zhang Y
    PLoS One; 2015; 10(12):e0144897. PubMed ID: 26683029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential patterns of histone methylase EHMT2 and its catalyzed histone modifications H3K9me1 and H3K9me2 during maturation of central auditory system.
    Ebbers L; Runge K; Nothwang HG
    Cell Tissue Res; 2016 Aug; 365(2):247-64. PubMed ID: 27083448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
    Shen X; Li Y; Xu Y; Liu M; Zhang Q; Yin R; Zhou M; Lin S; Fan H
    Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
    [No Abstract]   [Full Text] [Related]  

  • 16. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
    Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
    Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-species Analyses Unravel the Complexity of H3K27me3 and H4K20me3 in the Context of Neural Stem Progenitor Cells.
    Rhodes CT; Sandstrom RS; Huang SA; Wang Y; Schotta G; Berger MS; Lin CA
    Neuroepigenetics; 2016 Jun; 6():10-25. PubMed ID: 27429906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
    Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
    J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery.
    Watanabe T; Morinaga S; Akaike M; Numata M; Tamagawa H; Yamamoto N; Shiozawa M; Ohkawa S; Kameda Y; Nakamura Y; Miyagi Y
    Eur J Surg Oncol; 2012 Nov; 38(11):1051-7. PubMed ID: 22959167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global levels of histone modifications predict prostate cancer recurrence.
    Ellinger J; Kahl P; von der Gathen J; Rogenhofer S; Heukamp LC; Gütgemann I; Walter B; Hofstädter F; Büttner R; Müller SC; Bastian PJ; von Ruecker A
    Prostate; 2010 Jan; 70(1):61-9. PubMed ID: 19739128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.